GSTM1 and anemia: Females exhibited a notably higher prevalence (67.6%, 25/37) compared to males (62.2%, 61/98), despite the stricter diagnostic threshold for anemia in females (Hb <12 g/dL vs. Hb <13 g/dL for males).